CX 2024 Programme

Showing the latest CX 2024 Programme, talks, speakers and timings subject to change.
The organisers reserve the right to alter the programme as necessary.
All times are London time BST (British Summer Time), which is GMT+1. The organisers reserve the right to alter the timings if necessary.

Day 2 Afternoon: Peripheral Techniques & Technologies - Wednesday, 24th April
Venue:   Theatre 3
Time: 13:30 - 15:20
Inaugural Roger M Greenhalgh Late Breaking Trials Session
Time: 13:30 - 15:20
ATK Trials
Time: 13:30 - 14:35
Anchor:   Marianne Brodmann, Graz, Austria
Moderators:   Gunnar Tepe, Rosenheim, Germany
Thomas Zeller, Bad Krozingen, Germany
13:30 - 13:35
Achieving long term patency with a self-expanding covered endoprosthesis in the SFA: 5-year outcomes from the Japanese post-market study
Speaker:   Tatsuya Nakama, Chiba, Japan
13:35 - 13:40
New interwoven double mesh nitinol stent for femoropopliteal disease: Preliminary results from a multicenter regional registry
Speaker:   Gianmarco de Donato, Siena, Italy
13:40 - 13:45
ZILVERPASS trial 5-year results and economic analysis
Speaker:   Michel Bosiers, Bern, Switzerland
13:45 - 13:55
Audience participation & discussion
13:55 - 14:00
Podium First: 6-month data from the SHOCC study
Speaker:   Athanasios Saratzis, Leicester, United Kingdom
14:00 - 14:05
Podium First: First look at the PREVISION FIH Trial evaluating the novel sirolimus DCB catheter
Speaker:   Andrew Holden, Auckland, New Zealand
14:05 - 14:10
Audience participation & discussion
14:10 - 14:15
Podium First: Safety and efficacy metrics of a trans-venous arterial bypass system: Pooled analysis and comprehensive evaluation of current objective performance goals
Speaker:   Peter Schneider, San Francisco, United States
14:15 - 14:20
The impact of non-pulsatile deformations in native and treated femoropopliteal arteries
Speaker:   Christopher Cheng, Stanford, United States
14:20 - 14:25
STRIDE Study sub-analysis: Reported outcomes by sex and on patients receiving aspiration mechanical thrombectomy alone
Speaker:   Heiko Wendorff, Ebersberg, Germany
14:25 - 14:35
Audience participation & discussion
BTK Trials
Time: 14:35 - 15:20
Anchor:   Marianne Brodmann, Graz, Austria
Moderators:   Gunnar Tepe, Rosenheim, Germany
Thomas Zeller, Bad Krozingen, Germany
14:35 - 14:40
The TOBA II Study below-the-knee trial: 36-month results
Speaker:   Michael Lichtenberg, Arnsberg, Germany
14:40 - 14:45
Podium First: First results of the SAMBA Trial: A randomised trial comparing a paclitaxel DCB to POBA in BTK Arteries
Speaker:   Gunnar Tepe, Rosenheim, Germany
14:45 - 14:50
The use of combination directional atherectomy and DCB in tibial artery disease
Speaker:   Vikram Puttaswamy, St Leonards, Australia
14:50 - 15:00
Audience participation & discussion
15:00 - 15:05
Diagnosis of silent coronary ischaemia with selective coronary revascularisation might improve 2-year survival of patients with critical limb-threatening ischaemia
Speaker:   Dainis Krievins, Riga, Latvia
15:05 - 15:10
Podium First: Interim analysis of the DEEPER REVEAL trial
Speaker:   Mahmood Razavi, Stockton, United States
15:10 - 15:15
Podium First: Final results of the DEEPER LIMUS trial
Speaker:   Leyla Schweiger, Graz, Austria
15:15 - 15:20
Audience participation & discussion